![John Farah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Farah
Direktor/Vorstandsmitglied bei
POND TECHNOLOGIES HOLDINGS INC.
Vermögen: 446 $ am 31.05.2026
Profil
John Mitchell Farah is currently Director at Pond Technologies Holdings, Inc. since 2021.
Formerly, Dr. Farah was Independent Director at Rebus Holdings, Inc. from 2008 to 2010, Independent Director at Aeolus Pharmaceuticals, Inc. from 2011 to 2018, VP-International Pharmaceutical Operations at Cephalon LLC from 1992 to 2011, Chief Business Officer at Melior Discovery, Inc., and Discovery Research Scientist at G.D.
Searle & Co., Inc. Education includes undergraduate studies at New College of California and the University of Maryland, and a doctorate from the Uniformed Services University of the Health Sciences conferred in 1985.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 63 782 ( 0,07 % ) | 446 $ | 31.05.2026 |
Aktive Positionen von John Farah
| Unternehmen | Position | Beginn |
|---|---|---|
| POND TECHNOLOGIES HOLDINGS INC. | Direktor/Vorstandsmitglied | 14.07.2021 |
Ehemalige bekannte Positionen von John Farah
| Unternehmen | Position | Ende |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2018 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| INSPYR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 17.08.2010 |
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Provides in-vivo pharmacology services | Direktor/Vorstandsmitglied | 16.01.2013 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von John Farah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Provides in-vivo pharmacology services | Commercial Services |
Rebus Holdings, Inc.
 Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
Aeolus Pharmaceuticals, Inc.
 Aeolus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
New College of California
 New College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniformed Services University of the Health Sciences
 Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pond Technologies Holdings, Inc.
 Pond Technologies Holdings, Inc. Pharmaceuticals: OtherHealth Technology Engages in production and sale of nutraceutical and related products to business and retail customers | Health Technology |
